ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657271 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657271; 2) Community: the network communities that were significantly associated with the response to NSC 657271; 3) Molecule: the relationships between components within communities and NSC 657271; 4) MDR: the compounds that were significantly associated with the NSC 657271.

NSC Compound Enrichment Correlation
NSC 752892 N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide 0.0130238833303634 0.13323005
NSC 757795 BERBERINE CHLORIDE 0.0130238833303634 0.16998535
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.0130238833303634 0.42111299
NSC 759274 ARSENIC TRIOXIDE 0.0130238833303634 0.3556307
NSC 87500 Solacongestidine 0.0130238833303634 0.15656634
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0135714101922724 0.31869475
NSC 255105 GELDANAMYCIN ANALOG 0.0135714101922724 0.35530088
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.0135714101922724 0.36612315
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0135714101922724 0.25346659
NSC 46213 Null 0.0135714101922724 -0.11009308
Total:158  Current:68    [First] [Prev] [Next] [Last]